Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:948723.
doi: 10.1155/2015/948723. Epub 2015 Oct 29.

The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases

Andreia Bettencourt  1 , Cláudia Carvalho  1 , Bárbara Leal  1 , Sandra Brás  2 , Dina Lopes  2 , Ana Martins da Silva  3 , Ernestina Santos  4 , Tiago Torres  5 , Isabel Almeida  6 , Fátima Farinha  7 , Paulo Barbosa  8 , António Marinho  6 , Manuela Selores  9 , João Correia  7 , Carlos Vasconcelos  6 , Paulo P Costa  10 , Berta Martins da Silva  1
Affiliations

The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases

Andreia Bettencourt et al. J Immunol Res. 2015.

Abstract

Autoimmune diseases (AIDs) are characterized by a multifactorial aetiology and a complex genetic background, with the MHC region playing a major role. We genotyped for HLA-DRB1 locus 1228 patients with AIDs-213 with Systemic Lupus Erythematosus (SLE), 166 with Psoriasis or Psoriatic Arthritis (Ps + PsA), 153 with Rheumatoid Arthritis (RA), 67 with Systemic Sclerosis (SSc), 536 with Multiple Sclerosis (MS), and 93 with Myasthenia Gravis (MG) and 282 unrelated controls. We confirmed previously established associations of HLA-DRB1(∗)15 (OR = 2.17) and HLA-DRB1(∗)03 (OR = 1.81) alleles with MS, HLA-DRB1(∗)03 with SLE (OR = 2.49), HLA-DRB1(∗)01 (OR = 1.79) and HLA-DRB1(∗)04 (OR = 2.81) with RA, HLA-DRB1(∗)07 with Ps + PsA (OR = 1.79), HLA-DRB1(∗)01 (OR = 2.28) and HLA-DRB1(∗)08 (OR = 3.01) with SSc, and HLA-DRB1(∗)03 with MG (OR = 2.98). We further observed a consistent negative association of HLA-DRB1(∗)13 allele with SLE, Ps + PsA, RA, and SSc (18.3%, 19.3%, 16.3%, and 11.9%, resp., versus 29.8% in controls). HLA-DRB1(∗)13 frequency in the AIDs group was 20.0% (OR = 0.58). Although different alleles were associated with particular AIDs, the same allele, HLA-DRB1(∗)13, was underrepresented in all of the six diseases analysed. This observation suggests that this allele may confer protection for AIDs, particularly for systemic and rheumatic disease. The protective effect of HLA-DRB1(∗)13 could be explained by a more proficient antigen presentation by these molecules, favouring efficient clonal deletion during thymic selection.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Shoenfeld Y., Gilburd B., Abu-Shakra M., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases—2008. Israel Medical Association Journal. 2008;10(1):3–7. - PubMed
    1. Anaya J.-M., Gómez L., Castiblanco J. Is there a common genetic basis for autoimmune diseases? Clinical and Developmental Immunology. 2006;13(2–4):185–195. doi: 10.1080/17402520600876762. - DOI - PMC - PubMed
    1. Cruz-Tapias P., Pérez-Fernández O. M., Rojas-Villarraga A., Rodríguez-Rodríguez A., Arango M.-T., Anaya J.-M. Shared HLA class II in six autoimmune diseases in Latin America: a meta-analysis. Autoimmune Diseases. 2012;2012:10. doi: 10.1155/2012/569728.569728 - DOI - PMC - PubMed
    1. Anaya J. M. The autoimmune tautology. Arthritis Research & Therapy. 2010;12(6, article 147) doi: 10.1186/ar3175. - DOI - PMC - PubMed
    1. Smilek D. E., St Clair E. W. Solving the puzzle of autoimmunity: critical questions. F1000Prime Reports. 2015;7, article 17 doi: 10.12703/p7-17. - DOI - PMC - PubMed